1h Free Analyst Time
The bioprocess technology market is forecasted to grow by USD 48.3 billion during 2023-2028, accelerating at a CAGR of 11% during the forecast period. The report on the bioprocess technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in infectious diseases, increase in chronic diseases, and growing healthcare expenditure in developing countries.
The bioprocess technology market is segmented as below:
By End-user
- Biopharmaceutical companies
- Contract manufacturing organizations
- Academic research institute
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bioprocess technology market covers the following areas:
- Bioprocess Technology Market sizing
- Bioprocess Technology Market forecast
- Bioprocess Technology Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global bioprocess technology market: Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Eppendorf SE, Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips N.V., Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., and Univercells SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing clinical trials in countries."
According to the report, one of the major drivers for this market is the increase in infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Instruments LLC
- Becton Dickinson and Co.
- Boehringer Ingelheim International GmbH
- Catalent Inc.
- Charles River Laboratories International Inc.
- Corning Inc.
- Dover Corp.
- Emerson Electric Co.
- Eppendorf SE
- Fujifilm Diosynth Biotechnologies USA Inc.
- General Electric Co.
- Koninklijke Philips N.V.
- Lonza Group Ltd.
- Merck KGaA
- Nova Biomedical Corp.
- Repligen Corp.
- Sartorius AG
- STADA Arzneimittel AG
- Thermo Fisher Scientific Inc.
- Univercells SA
